FOX
57
2
SBUX
44
3
URI
50
7
GIS
57
2
IRM
41
7
MLM
63
3
NWL
61
3
PM
52
-4
FLR
46
3
PRU
62
2
NTAP
65
-2
BLK
61
6
DLTR
63
5
SE
47
-5
OMC
53
-2
LNC
65
3
KMB
45
-3
PNC
75
6
EQR
50
-3
APA
52
2
FOX
57
2
SBUX
44
3
URI
50
7
GIS
57
2
IRM
41
7
MLM
63
3
NWL
61
3
PM
52
-4
FLR
46
3
PRU
62
2
NTAP
65
-2
BLK
61
6
DLTR
63
5
SE
47
-5
OMC
53
-2
LNC
65
3
KMB
45
-3
PNC
75
6
EQR
50
-3
APA
52
2
Financhill
Back

Perspective Therapeutics, Inc. Stock Predictions

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
37

CATX
Perspective Therapeutics, Inc.

Last Price:
$2.4000
Seasonality Move:
21.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Missed $0.81? RAD Intel Now Open at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Perspective Therapeutics, Inc. Stock Forecast

  • Is Perspective Therapeutics, Inc. Stock Undervalued?
    The current Perspective Therapeutics, Inc. [CATX] share price is $2.2100. The Score for CATX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Perspective Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Perspective Therapeutics, Inc. Stock Rating

Data Unavailable

Perspective Therapeutics, Inc. Stock Price History

Is CATX stock going to rise?

  • The current trend is relatively stagnant and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com

52-Week Data

52-Week High:
5.3881
52-Week Low:
1.6000

Prediction Charts

Market Cap:
164.3M
Price in USD:
2.2100
Volume:
1.5M
Beta:
-73.6637

Technical Analysis

SMA50:
2.9742
SMA100:
3.3217
SMA200:
3.0148
52-Wk Change:
-44.75%

Stock Predictions

  • Is Perspective Therapeutics, Inc. stock public?
    Yes, Perspective Therapeutics, Inc. is a publicly traded company.
  • What is the Perspective Therapeutics, Inc. stock quote today?
    The Perspective Therapeutics, Inc. stock price is 2.2100 USD today.
  • How to buy Perspective Therapeutics, Inc. stock online?
    You can buy Perspective Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-13 2.1400 2.0700 2.1800 2.0000
Nov-14 2.1000 2.0800 2.2300 2.0400
Nov-17 2.1100 2.2100 2.3200 2.0750
Nov-18 2.1800 2.2800 2.3650 2.1700
Nov-19 2.3100 2.3000 2.5400 2.2900
Nov-20 2.3500 2.1200 2.4100 2.1000
Nov-21 2.1200 2.0900 2.1692 1.9550
Nov-24 2.1600 2.1700 2.3100 2.1400
Nov-25 2.2100 2.1900 2.2900 2.0700
Nov-26 2.2200 2.2300 2.2679 2.1700
Nov-28 2.2500 2.3500 2.3877 2.2500
Dec-1 2.3300 2.1900 2.3551 2.1500
Dec-2 2.1800 2.0500 2.1900 2.0500
Dec-3 2.0500 2.2100 2.2150 2.0500

Perspective Therapeutics, Inc. Earnings

Data Unavailable

Perspective Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and a decrease next year of $0.14 per share.

* Perspective Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.